The effects of beta-blockers on morbidity and mortality in a population-based cohort of 11,942 elderly patients with heart failure
- 1 December 2002
- journal article
- Published by Elsevier in The American Journal of Medicine
- Vol. 113 (8) , 650-656
- https://doi.org/10.1016/s0002-9343(02)01346-3
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- β-Blockers in Congestive Heart Failure: A Bayesian Meta-AnalysisAnnals of Internal Medicine, 2001
- Rate of heart failure and 1-year survival for older people receiving low-dose β-blocker therapy after myocardial infarctionThe Lancet, 2000
- Comparative Effects of Low and High Doses of the Angiotensin-Converting Enzyme Inhibitor, Lisinopril, on Morbidity and Mortality in Chronic Heart FailureCirculation, 1999
- Clinical outcomes in heart failure: report from a community hospital-based registryThe American Journal of Medicine, 1999
- Congestive Heart Failure in the CommunityCirculation, 1998
- Digoxin in heart failure: results of the recent digoxin investigation group trial in the context of other treatments for heart failureEuropean Heart Journal, 1997
- The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart FailureNew England Journal of Medicine, 1996
- Characteristics and mortality outcomes of thrombolysis trial participants and nonparticipants: A population-based comparisonJournal of the American College of Cardiology, 1996
- Effect of Enalapril on Survival in Patients with Reduced Left Ventricular Ejection Fractions and Congestive Heart FailureNew England Journal of Medicine, 1991
- DOUBLE-BLIND TRIAL OF CHRONIC ORAL BETA BLOCKADE IN CONGESTIVE CARDIOMYOPATHYThe Lancet, 1981